CompletedNCT00789113
Determination of Absorption and Elimination of Lamotrigine-XR
Medication studyAges 65+United StatesBipolarity
Understand this study
Who was this study for?
Listed age limits: from 65 years.
- Listed locations
- MinneapolisSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateNovember 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 12
- Sponsor
- University of Minnesota
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- Over 65 Years
- Official registry ID
- NCT00789113
- Official title
Show the full official title
Determination of Bioavailability and Clearance of Lamotrigine-XR by a Stable Isotope Technique
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Minneapolis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Minnesota, a university.
Did this study involve medication?
Yes. The study involved medication, including Extended Release Lamotrigine.
Who was this study for?
Listed age limits: from 65 years.
